Philippe Morice
Philippe Morice is an expert in Oncology at Institut Gustave Roussy (France). As of October 2026, ScienceLeadR ranks Philippe Morice in the top 1% of experts worldwide for Uterine Diseases, Ovarian Neoplasms and Adnexal Diseases. Philippe Morice has authored 615 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,750 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Gynecology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1994 - 2026
Number : 615
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Severe delayed diaphragmatic hernia with total gastric migration after cytoreductive surgery, a rare complication: A case report. PMID 42524256 — hernia, cytoreduction surgical procedures, ovary, drug therapy, ovarian neoplasms, risk factors, diagnosis, therapeutics, hernia, diaphragmatic, chemotherapy | Exp Ther Med | 2026 | 0 |
| Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases. PMID 41719896 — lymph nodes, lymph node excision, uterine cervical neoplasms, genital neoplasms, female, neoplasms, renal veins, positron emission tomography computed tomography, neoplasm metastasis, lymph, veins | Gynecol Oncol | 2026 | 0 |
| Fertility preservation in gynecologic oncology: evaluating knowledge, practices, and barriers among French healthcare providers. PMID 41494211 — fertility, genital neoplasms, female, fertility preservation, cryopreservation, oocytes, health personnel, tissues, reproductive medicine | Int J Gynecol Cancer | 2025 | 0 |
| Surgical treatment of vaginal and vulvar melanoma: a 18-year retrospective study. PMID 41485272 — melanoma, retrospective studies, therapeutics, prognosis | Eur J Surg Oncol | 2025 | 0 |
| Stage IA3 endometrial cancer in the FIGO 2023 classification: a case of clarity or complexity? PMID 41365076 — carcinoma, endometrioid, genital neoplasms, female, neoplasms, classification, therapeutics, endometrial neoplasms | Int J Gynecol Cancer | 2025 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map